Literature DB >> 30051928

A benchmarking study on virtual ligand screening against homology models of human GPCRs.

Victor Jun Yu Lim1,2, Weina Du1, Yu Zong Chen3, Hao Fan1,4,5.   

Abstract

G-protein-coupled receptor (GPCR) is an important target class of proteins for drug discovery, with over 27% of FDA-approved drugs targeting GPCRs. However, being a membrane protein, it is difficult to obtain the 3D crystal structures of GPCRs for virtual screening of ligands by molecular docking. Thus, we evaluated the virtual screening performance of homology models of human GPCRs with respect to the corresponding crystal structures. Among the 19 GPCRs involved in this study, we observed that 10 GPCRs have homology models that have better or comparable performance with respect to the corresponding X-ray structures, making homology models a viable choice for virtual screening. For a small subset of GPCRs, we also explored how certain methods like consensus enrichment and sidechain perturbation affect the utility of homology models in virtual screening, as well as the selectivity between agonists and antagonists. Most notably, consensus enrichment across multiple homology models often yields results comparable to the best performing model, suggesting that ligand candidates predicted with consensus scores from multiple models can be the optimal option in practical applications where the performance of each model cannot be estimated.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  G-protein-coupled receptor; GPCR; X-ray crystallography; consensus enrichment; homology modeling; virtual screening

Mesh:

Substances:

Year:  2018        PMID: 30051928     DOI: 10.1002/prot.25533

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  6 in total

Review 1.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

2.  Differential long-term regulation of TAS2R14 by structurally distinct agonists.

Authors:  Jung A Woo; Maria Castaño; Ashley Goss; Donghwa Kim; Eric M Lewandowski; Yu Chen; Stephen B Liggett
Journal:  FASEB J       Date:  2019-08-20       Impact factor: 5.191

3.  Drug-induced diabetes type 2: In silico study involving class B GPCRs.

Authors:  Dorota Latek; Ewelina Rutkowska; Szymon Niewieczerzal; Judyta Cielecka-Piontek
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

4.  Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity.

Authors:  Mariama Jaiteh; Ismael Rodríguez-Espigares; Jana Selent; Jens Carlsson
Journal:  PLoS Comput Biol       Date:  2020-03-13       Impact factor: 4.475

5.  Machine Learning Assisted Approach for Finding Novel High Activity Agonists of Human Ectopic Olfactory Receptors.

Authors:  Amara Jabeen; Claire A de March; Hiroaki Matsunami; Shoba Ranganathan
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

Review 6.  Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery.

Authors:  R N V Krishna Deepak; Ravi Kumar Verma; Yossa Dwi Hartono; Wen Shan Yew; Hao Fan
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.